INS and metabolic dysfunction-associated steatohepatitis: We observed that SERPINA12 expression was significantly increased in nonalcoholic steatohepatitis (NASH) patients compared with an in vitro human liver model (a condition of low glucose and low insulin to mimic the healthy liver) (Fig. 5D) (Feaver et al, 2016).